TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Genetic Technologies ( (AU:GTG) ) has provided an update.
Genetic Technologies Limited reported a 15% decrease in revenue for the half-year ending December 31, 2024, with a loss after tax down 36% to $2,332,662. The company’s net tangible assets per security also declined, reflecting financial challenges. Despite these setbacks, no dividends were declared for the current or previous financial periods. A significant share consolidation was undertaken, consolidating equity securities on a 1-for-100 basis, which was approved at the 2023 AGM.
More about Genetic Technologies
Genetic Technologies Limited operates in the biotechnology industry, focusing on genetic testing and diagnostics. The company provides products and services aimed at improving health outcomes through advanced genetic insights.
Technical Sentiment Signal: Sell
Current Market Cap: A$5.67M
See more insights into GTG stock on TipRanks’ Stock Analysis page.